Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Eloralintide for Sale > Custom Peptides Pure 98% Eloralintide CAS 2883634-40-8 LY3841136 AMY1176 Raw Powder
Custom Peptides Pure 98% Eloralintide CAS 2883634-40-8  LY3841136 AMY1176 Raw Powder buy - large image1
Custom Peptides Pure 98% Eloralintide CAS 2883634-40-8  LY3841136 AMY1176 Raw Powder buy - image1
Custom Peptides Pure 98% Eloralintide CAS 2883634-40-8  LY3841136 AMY1176 Raw Powder buy - image2
Custom Peptides Pure 98% Eloralintide CAS 2883634-40-8  LY3841136 AMY1176 Raw Powder buy - image3
Custom Peptides Pure 98% Eloralintide CAS 2883634-40-8  LY3841136 AMY1176 Raw Powder buy - image4
Custom Peptides Pure 98% Eloralintide CAS 2883634-40-8  LY3841136 AMY1176 Raw Powder buy - image5

Custom Peptides Pure 98% Eloralintide CAS 2883634-40-8 LY3841136 AMY1176 Raw Powder

81 Inquiries

Unit Price: Get Latest Price
CAS No.:

2883634-40-8

Grade:

Chemical Grade

Content:

99%

Port:

Shanghai

Brand:

Wuhan pnq

Packaging:

Aluminum foil bag

Price valid (until):

2026-08-20

Company Type:
Trader
Location:
China
Payment Terms:
100% TT in advance
Average Lead Time:
30 days
Qualification:
Main Products:

Apigenin,PQQ,NMNH

  • Product Details

  • Seller Information

  • Inquiry History

  • Description
    Shop PNQ supply Best Quality Lowest Price Dietary Supplement Beta Nicotinamide Mononucleotide Nmn CAS 1094-61-7-Detailed Image 1
    Shop Manufacturer Supply High Quality cucumber extract  Q-Actin-Detailed Image 2

    Shop Best Quality Lowest Price Skin Whitening Alpha Arbutin CAS-84380-01-8-Detailed Image 2


    Product Name  Eloralintide
    CAS NO. 2883634-40-8
    Purity   99%
    Molecular formula /
    MOQ  1 g


    Eloralintide is a selectiv amyli receptor agonist designed to treat obesity by activating the amyli 1 receptor (AM Y1R). In addition to weight loss, Eloralintide also leads to improvements in various metabolic parameters, including reduced waist circumference, improved lipid profiles, better blood sugar control, and decreased inflammatory markers.

    Shop PNQ supply Best Quality Lowest Price Dietary Supplement Beta Nicotinamide Mononucleotide Nmn CAS 1094-61-7-Detailed Image 2



    Q1: What's your MOQ?
    A:It depends on different products,we can accept sample order or provide free sample for your test.
    Q2:How about delivery leadtime?
    A:Delivery lead time: About 3-5 days after payment confirmed. (Chinese holiday not included)
    Q3: Is there a discount?
    A:Different quantity has different discount.
    Q4:How to start orders or make payments?
    A:Proforma invoice will be sent first after confirmation of order, enclosed our bank information.
    Q5: How do you treat quality complaint?
    A:First of all, our quality control will reduce the quality problem to near zero. If there is a real quality problem caused by us, we will send you free goods for replacement or refund your loss.
    Q6:We don't know you at all, how can we trust you?
    A: You are always warm welcomed to visit us at any time.Before we start B2B, MIC has audited our company on-spot and approved our credit.Commitment is the No.1 Point of our Enterprise's Value.
    Q7:Do you test all your goods before delivery?
    A:Yes, we have 100% test before delivery,International Authorized Third-Party Test for the products if you need are highly welcomed.
    ECHEMI Editorial Reference

    Eloralintide (CAS No. 2883634-40-8) is a long-acting amylin analog and peptide-based pharmaceutical ingredient. Its modified peptide structure features a methylene thioacetal bridge and a C20 fatty diacid side chain, contributing to its distinctive molecular and physicochemical properties. As a peptide pharmaceutical raw material, Eloralintide is suitable for API research, analytical studies, and pharmaceutical development.

    Basic Info
    Product Name:

    Eloralintide

    Other Name:

    Eloralintide;AMY1176;LY3841136;Eloralintide,LY3841136

    CAS No.:

    2883634-40-8

    Molecular Weight:

    0

    EC Number:

    262-076-3

    Color/Form:

    White to off-white

    Research
    Class:

    Amylin receptor (AMYR) agonist (peptide, long-acting)

    Status:

    Investigational — Phase 1/2 (T2DM and obesity)

    Mechanism:

    Eloralintide is an amylin receptor agonist developed by Eli Lilly for type 2 diabetes and obesity. It activates the amylin receptor (AMYR), reducing food intake, delaying gastric emptying, and promoting satiety. It is structurally distinct from cagrilintide (Novo Nordisk). Being explored as monotherapy and in combination with GLP-1R agonists.

    Activity note:

    Limited public data. Eloralintide is in early clinical development; specific EC50 values have not been publicly disclosed.

    Source:

    MCE: Eloralintide (CAS 2883634-40-8); AbMole product data sheet.

    References
    PubChem:

    PubChem

    Disclaimer:

    Eloralintide is NOT FDA-approved or EMA-approved. It is in Phase 1/2 clinical development by Eli Lilly. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Apigenin,PQQ,NMNH

    Location:

    Room 1006, Building C6, Economic Development Wanda, Caidian District, Wuhan City, Hubei Province

    Payment Terms:

    100% TT in advance

    Average lead Time:

    30 days

    Total Annual Revenue:

    Less than $1 million

    Total Employees:

    5-10

    Year of Establishment:

    2021

    Wuhan PNQ trade located in Wuhan, China, is an innovative natural products manufacturer and supplier that offers raw powders as dietary ingredients, food and beverage additives, sports nutrition supplements.

  • Inquiry History
    81 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Eloralintide

    1 KG May 28, 2026
    Australia

    ELORALINTIDE

    10 PCS Oct 2, 2026
    United Kingdom

    Eloralitide

    2 G Sep 27, 2026
    United Kingdom

    Eloralintide

    30 MG Sep 22, 2026
    United States

    Eloralintids

    10 MG Sep 18, 2026
    United States

    Eloralintide

    10 MG Sep 13, 2026
    United Kingdom

    Eloralintide

    1 G Sep 1, 2026
    United States

    Eloralintide

    1 MT Aug 31, 2026
    United States

    Eloralintide

    1 G Aug 27, 2026
    Italy

    Eloralintide

    5 PCS Aug 19, 2026
    United States

    eloralintide

    2 PCS Aug 2, 2026
    United States

    eloralintide

    30 MG Jul 28, 2026
    United States

    Elora

    32 G Jul 27, 2026
    United States

    Eloralintide

    1 G Jul 13, 2026
    United States

    Eloralintide

    10 PCS Jul 11, 2026
    Singapore

    Eloralintide

    1 G Jul 1, 2026
    United States

    eloralintide

    50 MT Jun 12, 2026
    United States

    Eloralintide and Retatrutide

    2 MT Jun 8, 2026
    United States

    Eloralintide

    5 PCS May 27, 2026
    South Korea

    eloralintide

    2 G Feb 24, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.